Sun Pharma
Tracked across 39 events · 1709 articles · First seen Jan 07, 2025 · Last active Jul 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
International
Impact: Sun Pharma was among the firms that saw declines in the S&P BSE Sensex.
Jan 08, 2026 · 7 articles
Tech
Impact: Sun Pharma is one of the 23 leading pharmaceutical companies included in the Indian Pharmaceutical Alliance, which is a partner in the Indian AI Research Organization (IAIRO) project.
Dec 30, 2025 · 7 articles
Business
Impact: Sun Pharma, a generic drug manufacturer, settled with UroGen Pharma Ltd. to receive a non-exclusive license to sell a generic version of Jelmyto starting September 15, 2030. This will introduce future competition for UroGen Pharma Ltd.'s product.
Jun 14, 2026 · 6 articles
Business
Impact: Sun Pharma was among the winning stocks, contributing to the overall market gains.
Jul 03, 2026 · 7 articles
Business
Impact: Sun Pharma is among the Indian generic drugmakers expected to introduce lower-priced versions of semaglutide after Semaglutide's patent expires.
Nov 11, 2025 · 6 articles
Regulatory
Impact: Sun Pharma is mentioned as a company from which Bleichmar Fonti & Auld LLP previously recovered value in a separate legal case, highlighting the law firm's track record.
May 22, 2026 · 57 articles
Business
Impact: Sun Pharma is mentioned as a company from which Bleichmar Fonti & Auld LLP previously recovered a significant amount in a separate legal action.
Aug 19, 2025 · 20 articles
Regulatory
Impact: Sun Pharma is mentioned as a past success for Bleichmar Fonti & Auld LLP, having recovered $420 million.
Nov 13, 2025 · 51 articles
Business
Impact: Sun Pharma is mentioned as a past success for Bleichmar Fonti & Auld LLP, where the firm recovered $420 million.
May 18, 2026 · 83 articles
Business
Impact: Sun Pharma is mentioned as a past success for Bleichmar Fonti & Auld LLP, where the firm recovered $420 million. This is a historical reference and not directly related to the current event.
May 18, 2026 · 300 articles
Regulatory
Impact: Sun Pharma is mentioned as a past success for BFA Law, where the firm recovered $420 million, further highlighting BFA's track record in securities class actions.
Jun 10, 2026 · 6 articles
+ 9 more events
View on Dashboard
60
UroGen Pharma settled with Sun PharmaUroGen Pharma CMO Sells Stock
Astec LifeSciences
competitor
↔
Sun Pharma
Sun Pharma competes directly with Astec LifeSciences and its related entities in
Abbott Laboratories
competitor
↔
Sun Pharma
Sun Pharmaceutical Industries acts as a major competitor to Abbott Laboratories
Astec LifeSciences
competitor
↔
Sun Pharma
Astec LifeSciences, alongside its associated life sciences brands, operates as a
Abbott Laboratories
competitor
↔
Sun Pharma
Abbott Laboratories competes directly with Sun Pharma in the global pharmaceutic
+ 2 more relationships
View on Dashboard
ERGEN INTELLIGENCE
Track Sun Pharma live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard